Related Experiment Video
Updated: Mar 5, 2026

12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.4K
The accessory gene regulator-1 as a therapeutic target for C. difficile infections
Charles Darkoh1,2, Herbert L DuPont1,2,3
1a University of Texas Health Science Center, School of Public Health, Department of Epidemiology , Human Genetics, and Environmental Sciences, Center For Infectious Diseases , Houston , TX , USA.
Expert Opinion on Therapeutic Targets
|March 25, 2017
Abstract
No abstract available in PubMed .
Keywords:
C. difficile Agr systemC. difficile pathogenesisC. difficile quorum sensingC. difficile virulenceaccesory genes regulator systembacterial pathogenesisMore Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
7.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K
Gene Regulation in Microbial Communities: Quorum Sensing
792
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
792
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56

